You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intermediate 1, Intermediate 2, CMML or High Risk MDS

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anemia, MDS, Chronic Myelomonocytic Leukemia Trial in France, United States (Sotatercept)

Completed
Has Results
  • Anemia
  • +5 more
  • Denver, Colorado
  • +19 more
Oct 20, 2022

MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) Trial in Huddinge, Uppsala (NEX-18a injection,

Terminated
  • Myelodysplastic Syndromes (MDS)
  • +2 more
  • NEX-18a injection
  • Azacitidine Injection
  • Huddinge, Sweden
  • +1 more
Apr 4, 2022

MDS Trial (Decitabine/Cedazuridine, Magrolimab)

Not yet recruiting
  • Myelodysplastic Syndromes
  • (no location specified)
Apr 18, 2023

Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Neoplasm
  • (no location specified)
Apr 24, 2023

MDS, MDS, Thrombocytopenia Trial (Placebo, Romiplostim)

Completed
Has Results
  • MDS
  • +2 more
  • Placebo
  • Romiplostim
  • (no location specified)
Nov 4, 2022

MDS, CMML, AML Trial in Canada, United States (SGI-110)

Completed
  • MDS
  • +2 more
  • Scottsdale, Arizona
  • +15 more
Apr 16, 2021

Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R Trial in Canada, United States (Etavopivat)

Recruiting
  • Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R
  • Ocala, Florida
  • +3 more
Jan 30, 2023

MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

Not yet recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Subcutaneous azacitidine
  • Oral decitabine/cedazuridine
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
May 29, 2023

Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])

Recruiting
  • Pre-fibrotic Myelofibrosis
  • Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
  • Taipei, Taiwan, 100, Taiwan
    National Taiwan University Hospital
Feb 7, 2023

Myelofibrosis Trial in Hangzhou (Jaktinib, Placebo to match Hydroxycarbamide, Hydroxycarbamide Tablets)

Recruiting
  • Myelofibrosis
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical School of Zhejiang Univ
Nov 28, 2022

Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

Not yet recruiting
  • Prostate Cancer
  • +4 more
  • (no location specified)
Aug 10, 2022

Pancreatic Fistula Trial in Cleveland (Piperacillin/Tazobactam, Amoxicillin/ Clavulanic acid)

Not yet recruiting
  • Pancreatic Fistula
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Feb 22, 2023

Azacitidine in International Prognostic Scoring System

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
    • Hefei, Anhui, China
    • +16 more
    Sep 6, 2022

    AML, MDS, Old Age; Debility Trial in Suzhou (Azacitidine, all trans retinoic acid)

    Recruiting
    • AML
    • +3 more
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Dec 27, 2021

    MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Oral Azacitidine
    • Placebo for Oral Azacitidine
    • Buenos Aires, Argentina
    • +1 more
    Aug 1, 2022

    MDS Trial in Bronx (Pyrimethamine)

    Withdrawn
    • Myelodysplastic Syndromes
    • Bronx, New York
      Montefiore Medical Center
    Sep 15, 2021

    Anemia in MDS Trial in Plantation, Bronx, Austin (TP-0184)

    Completed
    • Anemia in Myelodysplastic Syndromes
    • Plantation, Florida
    • +2 more
    Apr 4, 2022

    MDS, Chronic Myelomonocytic Leukemia (CMML) Trial (SNS-301)

    Withdrawn
    • Myelodysplastic Syndromes
    • Chronic Myelomonocytic Leukemia (CMML)
    • (no location specified)
    Aug 9, 2021

    MDS Trial in Beijing (Hetrombopag, Stanozolol Tablets)

    Not yet recruiting
    • MDS
    • Beijing, China
      Peking Union Medical College Hospital
    Sep 18, 2021

    Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

    Not yet recruiting
    • Breast Cancer, Early Breast Cancer
    • (no location specified)
    Jul 11, 2023

    MDS Trial in Worldwide (Talacotuzumab, Daratumumab)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • Saint Louis, Missouri
    • +20 more
    Dec 28, 2022

    MDS Trial in Miami, New York (50 gm CIVI/24 hours x 5 days every 4 week)

    Recruiting
    • Myelodysplastic Syndromes
    • 50 gm CIVI/24 hours x 5 days every 4 week
    • Miami, Florida
    • +1 more
    Jul 6, 2022

    Prostate Cancer Trial in Cleveland (Leuprolide acetate, Apalutamide, Radical prostatectomy)

    Completed
    Has Results
    • Prostate Cancer
    • Leuprolide acetate
    • +2 more
    • Cleveland, Ohio
      Cleveland Clinic, Case Comprehensive Cancer Center
    May 25, 2022

    Rectal Cancer Trial in Guangzhou (Sintilimab)

    Recruiting
    • Rectal Cancer
    • Guangzhou, Guangdong, China
      Department of colorectal surgery, the Sixth Affiliated Hospital,
    Jul 11, 2022

    Prostate Cancer Trial in Pittsburgh (18F-DCFPyL)

    Active, not recruiting
    • Prostate Cancer
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Mar 8, 2022